Literature DB >> 9479457

[The health of asylum seekers: from communicable disease screening to post-traumatic disorders].

L Loutan1, D Bierens de Haan, L Subilia.   

Abstract

As the end of this century approaches, the pressure of migration is increasing. It is difficult to limit with restrictive measures the number of refugees and persons seeking asylum in Europe in each country, medical screening programs are organised for arriving refugees and asylum seekers. In Switzerland, they are screened for tuberculosis and hepatitis B. They are offered standard vaccinations and immunized for hepatitis B according to screening results. The prevalence of tuberculosis in asylum seekers is 414 per 100,000, 227 per 100,000 of bacteriologically active tuberculosis. Anti-HBc antibody is present in 22% of women and 39% of men. The frequency increases with age and varies greatly according to origin. Initially, refugees were screened for intestinal parasites. Over a quarter were carriers, a large majority asymptomatic. Increasing numbers of asylum seekers come from countries affected by war and insecurity. Systematic screening carried out in Geneva for previous exposure to violence revealed that 61% reported major trauma, 18% reported torture and 37% complained of symptoms such as nightmares, insomnia, flashbacks, etc. The authors discuss issues related to medical screening programs, and their relative usefulness in an increasingly mobile world where the distinction between travellers and migrants is not always clear.

Entities:  

Mesh:

Year:  1997        PMID: 9479457

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  2 in total

1.  The evolution of a healthcare interpreting service mapped against the bilingual health communication model: a historical qualitative case study.

Authors:  Alexander Bischoff
Journal:  Public Health Rev       Date:  2020-08-04

Review 2.  Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence.

Authors:  Jonathan A Patz; Peter Daszak; Gary M Tabor; A Alonso Aguirre; Mary Pearl; Jon Epstein; Nathan D Wolfe; A Marm Kilpatrick; Johannes Foufopoulos; David Molyneux; David J Bradley
Journal:  Environ Health Perspect       Date:  2004-07       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.